COMMUNIQUÉS West-GlobeNewswire

Wildflower Experience Shop-in-Shop Retail Launches in New York City
09/01/2019
VANCOUVER, British Columbia, Jan. 09, 2019 (GLOBE NEWSWIRE) -- Wildflower Brands Inc. (CSE: SUN , OTC: WLDFF ) (the “ Company ”), is excited to announce the opening of our first shop-in-shop partnership with Retail Worx [...]
Exclusive Interview: Lexaria CEO Discusses Progress & Plans at O’Cannabiz 2018 -- CFN Media
09/01/2019
SEATTLE, Jan. 09, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
OncBioMune Announces Former Puma Biotechnology Executive and Genentech Veteran Brian Barnett, M.D., as Chief Executive Officer
09/01/2019
BATON ROUGE, La., Jan. 09, 2019 (GLOBE NEWSWIRE) -- OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" or the "Company"), a clinical-stage biopharmaceutical company engaged in the development of a proprietary [...]
Moving forward with Cannabis Sales License, Abba Medix Eyes EU-GMP Certification, Signs Agreement with Cannabis OneFive, Inc.
09/01/2019
TORONTO, Jan. 09, 2019 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (“Canada House” or the “Company”) (CSE:CHV) through its wholly owned subsidiary Abba Medix Corp. (“Abba”) has initiated the process for its [...]
Southeastern Grocers Partner with eTrueNorth to Launch CLIA-waived Laboratory for Point-of-Care Testing at Local Pharmacies
09/01/2019
BI-LO, Fresco y Más, Harveys Supermarket and Winn-Dixie pharmacies will accept eLabNetwork® vouchers and provide onsite wellness screenings FORT WORTH, Texas, Jan. 09, 2019 (GLOBE NEWSWIRE) -- e TrueNorth, the premier, [...]
Acasti Pharma Awarded Broad Composition-of-Matter and Method of Use Patents by the European Patent Office
09/01/2019
LAVAL, Québec, Jan. 09, 2019 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of [...]
CareDx to Present New AlloSure® Data at American Society of Transplant Surgeons Winter Symposium
09/01/2019
AlloSure utility studied in patients with delayed graft function BRISBANE, Calif., Jan. 09, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a molecular diagnostics company focused on the discovery, development and [...]
Pluristem Therapeutics Reports Successful Case Study in Treatment of Buerger’s Disease Patient
09/01/2019
Buerger’s disease is a severe vascular inflammatory disease associated with high risk of amputation Patient was at a pre-amputation stage and was treated with PLX-PAD cell therapy under compassionate use treatment After [...]
Cancer Genetics Strengthens Management Team with Appointment of William Finger as Executive Vice President, Precision Medicine and Pharma Services
09/01/2019
Executive appointment underscores continued execution of new corporate strategy of expanding Biopharma and Discovery businesses RUTHERFORD, N.J. and RESEARCH TRIANGLE PARK, N.C., Jan. 09, 2019 (GLOBE NEWSWIRE) -- Cancer [...]
Verona Pharma Receives WHO Approval for “ensifentrine” as Recommended INN for RPL554
09/01/2019
Assignment of the “-fentrine” stem in the INN attests to RPL554’s dual phosphodiesterase inhibitor mechanism of action LONDON, Jan. 09, 2019 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) (“Verona Pharma [...]
Rafael Pharmaceuticals Announces Initiation of Phase II Trial of CPI-613 in Combination with Modified FOLFIRINOX in Locally Advanced Pancreatic Cancer
09/01/2019
Newark, NJ, Jan. 09, 2019 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc., a leader in the growing field of cancer metabolism-based therapeutics, today announced the initiation of a phase II open-label trial in [...]
Akorn Receives FDA Warning Letter
09/01/2019
LAKE FOREST, Ill., Jan. 09, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, announced that it received a warning letter, dated January 4, from the U.S. Food and [...]
Moleculin Announces Patient Recruitment Begins in Annamycin Clinical Trial In Poland
09/01/2019
Received European approval to ship Annamycin into Poland to start treating patients HOUSTON, Jan. 09, 2019 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage [...]
Nephros Announces Preliminary Financial Results for Fiscal Year 2018
09/01/2019
Anticipates $5.6-5.7 Million Total Revenue; Product Revenue Growth Over 50% SOUTH ORANGE, NJ, Jan. 09, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company [...]
CURE Pharmaceutical To Present at Benzinga Cannabis Capital Conference
09/01/2019
LOS ANGELES, Jan. 09, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced that it will host an investor presentation at the Benzinga Cannabis [...]
Resonant Inc. Adds New Filter IP Standard Library and 5G Information to Company Website
09/01/2019
Provides additional information on website for new Filter IP Standard Library, including roadmap Unveils XBAR 5G video GOLETA, Calif., Jan. 09, 2019 (GLOBE NEWSWIRE) -- Resonant Inc. (NASDAQ: RESN), a leader in [...]
Integra LifeSciences Appoints Rhonda Germany Ballintyn as Director
09/01/2019
PLAINSBORO, N.J., Jan. 09, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global medical technology company, today announced the appointment of Rhonda Germany Ballintyn to [...]
Athenex Announces Completion of Target Enrollment in the Oraxol Phase III Study
09/01/2019
BUFFALO, N.Y., Jan. 09, 2019 (GLOBE NEWSWIRE) -- Athenex, Inc. (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]
Assertio Therapeutics Announces Amendment of its Senior Secured Credit Facility
09/01/2019
Agreement Provides Greater Financial Flexibility as Company Continues to Reduce Debt LAKE FOREST, Ill., Jan. 09, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) today announced that it has amended [...]

Pages